- Obesity Genes Mean Some Folks Must Exercise More for Same Results
- SCOTUS Appears Skeptical of Arguments to Curb Abortion Pill Access
- Sleep Troubles Can Raise Your Blood Pressure: Study
- ADHD Meds Tied to Heart Damage in Young Adult Users
- Could Regular Exercise Cure Your Insomnia? New Research Says Yes
- Black Men Less Likely to Receive Heart Transplants Than White Men or Women
- Could Deep Frying Foods Harm the Brain? Rat Study Suggests It Might
- Human Brains Are Getting Larger With Each Generation
- Animals Catch More Viruses From Us Than We Do From Them
- Young Adults With Migraine May Face Higher Stroke Risk
Implanted Device Approved to Decrease Seizures
A device implanted within the skull to help reduce the frequency of epileptic seizures has been approved by the U.S. Food and Drug Administration.
The RNS Stimulator is placed under the scalp and sends electrical pulses to the part of the brain where seizures are suspected to originate, the agency said in a news release.
Epilepsy, estimated to affect nearly 3 million people in the United States, is the third most common neurological disorder behind Alzheimer’s disease and stroke. Some 40 percent of those treated for epilepsy continue to have seizures, the FDA said.
Approval for the new device was based on clinical studies involving 191 people with drug-resistant epilepsy. Three months after the device was implanted, participants had about 38 percent fewer seizures per month compared to a 17 percent decrease in seizures among people who had the implanted device turned off, the FDA said. The most common adverse reactions included implant site infection and premature battery discharge.
People who have had the device implanted cannot have magnetic resonance imaging (MRI) or similar procedures, which could lead to permanent brain damage, the FDA noted.
The RNN Stimulator is produced by Neurospace Inc., based in Mountain View, Calif.
More information
For more about epilepsy, visit the U.S. National Institute of Neurological Disorders and Stroke.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.